TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11049921

Group type: EXPERIMENTAL
Intervention: Face mask ventilation (FM)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Laryngoscope‐guided orotracheal intubation (OETT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Esophageal tracheal Combitube insertion (ETC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask insertion with fiberscope‐guided tracheal intubation (ILM‐OETT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway insertion (LMA)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Maximum head‐neck flexion (FLEX‐MAX)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Maximum head‐neck extension (EXT‐MAX)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fiberscope‐guided nasal intubation (FOS‐NETT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: FLEX‐MAX
Number of subjects: 10
Study: 10164145

Group type: EXPERIMENTAL
Intervention: Primary interventions based on randomised controlled trials or systematic reviews
Number of subjects: 40
Study: 1449620

Group type: EXPERIMENTAL
Intervention: Chemotherapy regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simple chemotherapy regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (autologous or allogeneic)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental methods (biologic and immune response modifiers)
Number of subjects: 0
Study: 3883261

Group type: EXPERIMENTAL
Intervention: Clinical estimation of fetal weight
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Ultrasonographic methods
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Regression equation using ultrasonically measured fetal abdominal circumference
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: All three methods of estimating fetal weight
Number of subjects: 62
Study: 31960409

Group type: EXPERIMENTAL
Intervention: Liberal transfusion thresholds (105 g/l, maintaining 110-125 g/l)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Restrictive transfusion thresholds (80 g/l, to maintain haemoglobin 85-100 g/l)
Number of subjects: 38
Study: 30575473

Group type: EXPERIMENTAL
Intervention: Radical Prostatectomy
Number of subjects: 695

Group type: COMPARATOR
Intervention: Watchful Waiting
Number of subjects: 695
Study: 27455842

Group type: EXPERIMENTAL
Intervention: 750 mg peri-articular TXA
Number of subjects: 60

Group type: COMPARATOR
Intervention: 750 mg IV TXA
Number of subjects: 60
Study: 24917354

Group type: EXPERIMENTAL
Intervention: Low-volume, high-intensity aerobic interval training (HAIT), 18 min, 180 kcal per session
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-volume, high-intensity aerobic interval training (HAIT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-volume, moderate-intensity continuous aerobic training (CAT), 45 min, 360 kcal per session
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-volume, moderate-intensity continuous aerobic training (CAT)
Number of subjects: 24
Study: 23289194

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bezafibrate (400 mg daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination of Simvastatin and Bezafibrate
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non-diabetic control subjects
Number of subjects: 14
Study: 20394879

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 1595

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 1595
Study: 18715206

Group type: EXPERIMENTAL
Intervention: Insulin glargine (Lantus)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Insulin glulisine (Apidra)
Number of subjects: 60
Study: 15741724

Group type: EXPERIMENTAL
Intervention: 20% (w/v) sucrose plus 70 microg Fe/ml
Number of subjects: 16

Group type: COMPARATOR
Intervention: 20% (w/v) sucrose
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 20% (w/v) sucrose plus 18 microg Fe/ml
Number of subjects: 16

Group type: COMPARATOR
Intervention: water
Number of subjects: 16
Study: 14651815

Group type: EXPERIMENTAL
Intervention: Clinical and statistical review group
Number of subjects: 43

Group type: COMPARATOR
Intervention: Clinical review group
Number of subjects: 43
Study: 10800070

Group type: EXPERIMENTAL
Intervention: CD34+ cell dose greater than 5 x 106/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CD34+ cell dose higher than 5 x 106/kg
Number of subjects: 28

Group type: COMPARATOR
Intervention: CD34+ cell dose lower than 5 x 106/kg
Number of subjects: 28
Study: 8695127

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 1476283

Group type: COMPARATOR
Intervention: 4% albumin (up to 21)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Elohes (1.51)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Elohes and albumin
Number of subjects: 16
Study: 6330875

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 30733025

Group type: EXPERIMENTAL
Intervention: Adductor Canal Nerve Blockade (ACB)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Femoral Nerve Blockade (FNB)
Number of subjects: 90
Study: 30419828

Group type: EXPERIMENTAL
Intervention: Low-risk lifestyle class (14.4%)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Intermediate-risk lifestyle class (54.6%)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: High-risk lifestyle class (31%)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Age increase
Number of subjects: 750

Group type: COMPARATOR
Intervention: Marital status (widowed or divorced)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Higher education level
Number of subjects: 750
Study: 27653564

Group type: EXPERIMENTAL
Intervention: Nasal high-flow therapy
Number of subjects: 564

Group type: COMPARATOR
Intervention: Nasal CPAP
Number of subjects: 564
Study: 27858768

Group type: EXPERIMENTAL
Intervention: Aerobic and strengthening exercise
Number of subjects: 14
Study: 20843512

Group type: EXPERIMENTAL
Intervention: CoolGard 3000™ system and Icy™ catheter
Number of subjects: 7

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 7
Study: 19855988

Group type: EXPERIMENTAL
Intervention: SabreSource image guidance system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fluoroscopy-guided thermal ablation therapy
Number of subjects: 20
Study: 16934334

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 437

Group type: COMPARATOR
Intervention: Control group (non-suicidal)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Resolved suicidality
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Emergent and persistent suicidality
Number of subjects: 437
Study: 16401533

Group type: EXPERIMENTAL
Intervention: Physio ring (n = 43)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Classic ring (n = 53)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 96
Study: 12437255

Group type: EXPERIMENTAL
Intervention: Supervised training using a VR simulator
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no further training)
Number of subjects: 21
Study: 10759736

Group type: EXPERIMENTAL
Intervention: Pancreaticogastrostomy (PG)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Pancreaticojejunostomy (PJ)
Number of subjects: 142
Study: 8712826

Group type: EXPERIMENTAL
Intervention: MMC (4 mg, twice a week, total 1 mg/kg) + OK-432 (or PSK)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: MMC + OK-432 + HCFU (600 mg, per day)
Number of subjects: 185
Study: 1559386

Group type: EXPERIMENTAL
Intervention: Timolol (TIM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Betaxolol (BET)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 20
Study: 4035328

Group type: EXPERIMENTAL
Intervention: sn‐polyenylphosphatidylcholin (PPC) 450 mg b.i.d. (three times daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: sn‐polyenylphosphatidylcholin (PPC)
Number of subjects: 27
Study: 30826585

Group type: EXPERIMENTAL
Intervention: Unconditional cash transfer program
Number of subjects: 0
Study: 30232708

Group type: EXPERIMENTAL
Intervention: Calgranulin A high expression
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Calgranulin A low expression
Number of subjects: 158
Study: 25945816

Group type: EXPERIMENTAL
Intervention: Practicing under desirable difficulty conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition with predefined random order for difficulty levels
Number of subjects: 0
Study: 24285336

Group type: EXPERIMENTAL
Intervention: Supervised walking (60 min three times weekly for 3 months)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard care for physical activity and weight reduction
Number of subjects: 78
Study: 22465641

Group type: EXPERIMENTAL
Intervention: Balloon kyphoplasty
Number of subjects: 3

Group type: COMPARATOR
Intervention: Vertebroplasty
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Shield kyphoplasty
Number of subjects: 3
Study: 20122451

Group type: EXPERIMENTAL
Intervention: Inhaled β2-agonists (formoterol, salbutamol, salmeterol, terbutaline)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 17633360

Group type: EXPERIMENTAL
Intervention: Feiji Recipe (FJR)
Number of subjects: 60
Study: 16075346

Group type: EXPERIMENTAL
Intervention: Cryopreserved cadaver femoral vein allografts (SYN)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Polytetrafluoroethylene (PTFE) grafts
Number of subjects: 54
Study: 12153065

Group type: EXPERIMENTAL
Intervention: Self-administered history questionnaire
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group (no history questionnaire)
Number of subjects: 241
Study: 10420815

Group type: COMPARATOR
Intervention: Interferon-alpha
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy
Number of subjects: 0
Study: 8928582

Group type: EXPERIMENTAL
Intervention: ATS (autotransfusion system)
Number of subjects: 82

Group type: COMPARATOR
Intervention: nonATS (no autotransfusion system)
Number of subjects: 82
Study: 1979796

Group type: EXPERIMENTAL
Intervention: Cetirizine (5 to 20 mg once daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydroxyzine (25 to 75 mg/day in divided doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30148752

Group type: EXPERIMENTAL
Intervention: Complete Mesocolic Excision (CME)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Noncomplete Mesocolic Excision (NCME)
Number of subjects: 330
Study: 31326304

Group type: EXPERIMENTAL
Intervention: Daily oral l-arginine plus tadalafil
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108

Group type: COMPARATOR
Intervention: Single drugs (either l-arginine or tadalafil)
Number of subjects: 108
Study: 28012273

Group type: EXPERIMENTAL
Intervention: During menstruation (days 1-7)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Outside menstruation (any day after menstruation without vaginal blood loss)
Number of subjects: 112
Study: 26051738

Group type: EXPERIMENTAL
Intervention: Oxaliplatin combined with flurouracil
Number of subjects: 60

Group type: COMPARATOR
Intervention: FOLFOX4 (control)
Number of subjects: 60
Study: 23790420

Group type: EXPERIMENTAL
Intervention: Night extension orthosis plus hand therapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Hand therapy alone
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Total sample
Number of subjects: 56
Study: 21871480

Group type: EXPERIMENTAL
Intervention: General SMS-text reminder
Number of subjects: 385

Group type: COMPARATOR
Intervention: Informative SMS-text reminder
Number of subjects: 385
Study: 19339412

Group type: EXPERIMENTAL
Intervention: Hemoglobin target of 13.5 to 14.5 g/dl
Number of subjects: 596

Group type: COMPARATOR
Intervention: Hemoglobin target of 9.5 to 11.5 g/dl
Number of subjects: 596
Study: 16479247

Group type: EXPERIMENTAL
Intervention: Striatal dopamine transporter density in ADHD patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 20
Study: 14683745

Group type: EXPERIMENTAL
Intervention: Stents
Number of subjects: 8004
Study: 11137633

Group type: COMPARATOR
Intervention: No protective layer (Group 1)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide base (Group 2)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Glass ionomer cement (Group 3)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide base + glass ionomer cement (Group 4)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Shallow and medium depth cavities
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Newer generation dentine‐bonding agents
Number of subjects: 319
Study: 9542612

Group type: EXPERIMENTAL
Intervention: Milk challenge
Number of subjects: 20
Study: 7869013

Group type: EXPERIMENTAL
Intervention: Perindopril (4 to 8 mg) monotherapy
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Perindopril (4 to 8 mg) in combination with hydrochlorothiazide (50 mg/day)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 2832030

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH, Enoxaparine) 60 mg daily
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH, Enoxaparine) 40 mg daily
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH, Enoxaparine) 20 mg daily
Number of subjects: 892

Group type: COMPARATOR
Intervention: Unfractionated heparin (UH) 5000 units daily
Number of subjects: 892
Study: 31980285

Group type: EXPERIMENTAL
Intervention: Lorcaserin (10 mg BID)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (0 mg BID)
Number of subjects: 12
Study: 29220627

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Active Control Group
Number of subjects: 28
Study: 28160750

Group type: EXPERIMENTAL
Intervention: RPMS+training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham+training
Number of subjects: 21
Study: 26112014

Group type: EXPERIMENTAL
Intervention: Weight management programme
Number of subjects: 148
Study: 24306011

Group type: EXPERIMENTAL
Intervention: Accelerated Resolution Therapy (ART)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 57
Study: 20515235

Group type: EXPERIMENTAL
Intervention: Randomized single-case intervention designs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional single-case designs
Number of subjects: 0
Study: 17976888

Group type: EXPERIMENTAL
Intervention: 2h training
Number of subjects: 1095

Group type: EXPERIMENTAL
Intervention: 4h training
Number of subjects: 1095

Group type: EXPERIMENTAL
Intervention: 7h training
Number of subjects: 1095

Group type: EXPERIMENTAL
Intervention: 6-month retest
Number of subjects: 1095

Group type: COMPARATOR
Intervention: No 6-month retest
Number of subjects: 1095
Study: 16386812

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 117

Group type: COMPARATOR
Intervention: No alcohol
Number of subjects: 117
Study: 14703598

Group type: EXPERIMENTAL
Intervention: Combination of CRP > 10 pg/mL plus IL‐6 > 18 pg/mL at 0-hour
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: CRP at 24-hours
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: IL‐6 at 0-hour
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: IL‐8 at 24-hours
Number of subjects: 105
Study: 10716520

Group type: EXPERIMENTAL
Intervention: Beta-blockers (n = 33)
Number of subjects: 65

Group type: COMPARATOR
Intervention: No beta-blockers (n = 32)
Number of subjects: 65
Study: 8852689

Group type: EXPERIMENTAL
Intervention: Bilateral stimuli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unilateral stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extinguished stimulus on the field contralateral to the lesion
Number of subjects: 0
Study: 1641252

Group type: EXPERIMENTAL
Intervention: Treatment (expulsion of Trichuris trichiura)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control (uninfected children)
Number of subjects: 159
Study: 6829944

Group type: EXPERIMENTAL
Intervention: Isoflurane at 3.5% concentration
Number of subjects: 60

Group type: COMPARATOR
Intervention: Atropine 0.02 mg/kg intramuscularly before induction
Number of subjects: 60
Study: 31860965

Group type: EXPERIMENTAL
Intervention: N2O titration (30% to ideal sedation concentration)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 50% N2O (control)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: N2O titration
Number of subjects: 70
Study: 29726999

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone (MPA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 28
Study: 27418682

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (11.91 mmol nitrate)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (placebo, 0.01 mmol nitrate)
Number of subjects: 31
Study: 24595714

Group type: EXPERIMENTAL
Intervention: Educational intervention delivered by community health workers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (received educational pamphlets)
Number of subjects: 0
Study: 22951193

Group type: EXPERIMENTAL
Intervention: Injection of methylprednisolonacetate
Number of subjects: 160

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 160
Study: 20233176

Group type: EXPERIMENTAL
Intervention: Homoeopathic granules
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 18569053

Group type: EXPERIMENTAL
Intervention: Highly structured approach
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Guided exercise approach
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Circuit training approach
Number of subjects: 52
Study: 16421163

Group type: EXPERIMENTAL
Intervention: Epoetin, 50 units/kg once per week
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Epoetin (in vitro treatment of PBMs)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (normolipidemic healthy volunteers)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group II (untreated patients)
Number of subjects: 48
Study: 12671377

Group type: EXPERIMENTAL
Intervention: Vivostat patient-derived fibrin sealant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thrombin solution (control)
Number of subjects: 0
Study: 10561316

Group type: EXPERIMENTAL
Intervention: Mitoxantrone and hydrocortisone (M+H)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Hydrocortisone alone
Number of subjects: 242
Study: 8916861

Group type: EXPERIMENTAL
Intervention: Preincisional infiltration of the tonsils with bupivacaine hydrochloride
Number of subjects: 129
Study: 1882909

Group type: EXPERIMENTAL
Intervention: Sucralfate (1-g tablet twice a day for 4 months)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 6133059

Group type: EXPERIMENTAL
Intervention: 70 mmol sodium alpha‐ketoisocaproate (KIC)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 70 mmol leucine
Number of subjects: 21

Group type: COMPARATOR
Intervention: 10 g glucose plus 70 mmol NaHCO3
Number of subjects: 21
Study: 29143290

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 32

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 32
Study: 28125980

Group type: EXPERIMENTAL
Intervention: Combined music and touch intervention (CMT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no CMT)
Number of subjects: 62
Study: 25449185

Group type: EXPERIMENTAL
Intervention: YOCAS©® intervention (4-week yoga intervention)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 97
Study: 23223405

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 3942

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 3942
Study: 21986165

Group type: EXPERIMENTAL
Intervention: Liquid-based cytology (LBC)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional smear method (SMEAR)
Number of subjects: 58
Study: 17970794

Group type: EXPERIMENTAL
Intervention: Restrictive episiotomy policy
Number of subjects: 774

Group type: COMPARATOR
Intervention: Routine episiotomy policy
Number of subjects: 774
Study: 16449709

Group type: EXPERIMENTAL
Intervention: Benzodiazepine tapering-off programme without psychotherapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 102
Study: 12882612

Group type: EXPERIMENTAL
Intervention: Individual ratings by 11 raters
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Consensus ratings by groups of 2 or 3 raters
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Total score by individual raters
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Total score by consensus ratings
Number of subjects: 145
Study: 11710399

Group type: EXPERIMENTAL
Intervention: Chromium picolinate (CrPic) supplementation (500 ug once per day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Chromium picolinate (CrPic) supplementation
Number of subjects: 15
Study: 9419047

Group type: EXPERIMENTAL
Intervention: ALSFRS (Amyotrophic Lateral Sclerosis Functional Rating Scale)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (from ALS CNTF Treatment Study)
Number of subjects: 0
Study: 8272248

Group type: EXPERIMENTAL
Intervention: Duo-Flux Artificial Kidney
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: F 60
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filtral
Number of subjects: 0

Group type: COMPARATOR
Intervention: cuprammonium cellulose plate
Number of subjects: 0

Group type: COMPARATOR
Intervention: CD 4000
Number of subjects: 0